<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02270047</url>
  </required_header>
  <id_info>
    <org_study_id>B315</org_study_id>
    <nct_id>NCT02270047</nct_id>
  </id_info>
  <brief_title>SATIN The Acute Effect of Orange Nectar With NAXUS Fibre Made by Novel Processing on Satiety and Satiation</brief_title>
  <acronym>SATIN</acronym>
  <official_title>SATIN The Acute Effect of Orange Nectar With NAXUS Fibre Made by Novel Processing on Satiety and Satiation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Leeds</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Liverpool</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A 4 week double blinded parallel design with an intervention condition and a control&#xD;
      condition will be employed. After having completed screening procedure and a baseline test&#xD;
      day, participants will be randomized to either intervention or control condition. In the&#xD;
      following 4 weeks, the participants will have to consume the distributed food product daily&#xD;
      before completing another test day.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>AD libitum energy intake</measure>
    <time_frame>week0, week 4</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>VAS score for appetite sensation</measure>
    <time_frame>Week 0, week 4</time_frame>
    <description>Perceptions of hunger, fullness, desire to eat, prospective consumption will be assessed using 100 mm VAS scales</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Eating behaviour</measure>
    <time_frame>week 0 week 4</time_frame>
    <description>Eating behaviour will be assessed by the binge eating scale from Gormally et al. 1982, the Control og Eating questionnaire by Hill et al. 1991, the Power og food scale by Lowe et al 2009, and the Three Factor Eating Questionnaire by Stunkard and Messick, 1985</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Appetite</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Orange nectar with NAXUS fibre, 5g/100mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Orange nectar</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Orange nectar</intervention_name>
    <description>Orange nectar</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Orange Nectar with fibre</intervention_name>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants who have provided written informed consent&#xD;
&#xD;
          -  BMI between 23.0-27.9 kg/m2&#xD;
&#xD;
          -  Regular breakfast eaters (eating breakfast ≥ 4 times a week)&#xD;
&#xD;
          -  Regular menstrual periods&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant health problems as judged by the investigator&#xD;
&#xD;
          -  Taking any medication or supplements known to affect appetite or body weight within&#xD;
             the past month and/or during the study as judged by the investigator&#xD;
&#xD;
          -  Pregnant, planning to become pregnant within the next 4 weeks or breastfeeding&#xD;
&#xD;
          -  History of anaphylaxis to food&#xD;
&#xD;
          -  Any known food allergies or food intolerance, specifically the below listed:&#xD;
&#xD;
               1. Cereals containing gluten, namely: wheat, rye, barley, oats, spelt, kamut or&#xD;
                  their hybridised strains, and products thereof;&#xD;
&#xD;
               2. Crustaceans and products thereof;&#xD;
&#xD;
               3. Eggs and products thereof;&#xD;
&#xD;
               4. Fish and products thereof;&#xD;
&#xD;
               5. Peanuts and products thereof;&#xD;
&#xD;
               6. Soybeans and products thereof;&#xD;
&#xD;
               7. Milk and products thereof (including lactose);&#xD;
&#xD;
               8. Nuts, namely: almonds (Amygdalus communis L.), hazelnuts (Corylus avellana),&#xD;
                  walnuts (Juglans regia), cashews (Anacardium occidentale), pecan nuts (Carya&#xD;
                  illinoinensis (Wangenh.) K. Koch), Brazil nuts (Bertholletia excelsa), pistachio&#xD;
                  nuts (Pistacia vera), macadamia or Queensland nuts (Macadamia ternifolia), and&#xD;
                  products thereof, except for nuts used for making alcoholic distillates including&#xD;
                  ethyl alcohol of agricultural origin;&#xD;
&#xD;
               9. Celery and products thereof;&#xD;
&#xD;
              10. Mustard and products thereof;&#xD;
&#xD;
              11. Sesame seeds and products thereof;&#xD;
&#xD;
              12. Sulphur dioxide and sulphites;&#xD;
&#xD;
              13. Lupin&#xD;
&#xD;
              14. Molluscs&#xD;
&#xD;
          -  Smoking, smoking cessation within the past 3 months or nicotine use (electronic&#xD;
             cigarettes)&#xD;
&#xD;
          -  Self-reporting currently dieting or having lost/gained significant amount of weight&#xD;
             (±3 kg) in the previous 3 months&#xD;
&#xD;
          -  Significant changes in physical activity patterns in the past 4 weeks or intention to&#xD;
             change during the study as judged by the investigator&#xD;
&#xD;
          -  Significant change in diet in the past 4 weeks or intention to change the diet during&#xD;
             the study as judged by the investigator&#xD;
&#xD;
          -  Use of systemic or local treatment likely to interfere with evaluation of the study&#xD;
             parameters as judged by the investigator&#xD;
&#xD;
          -  Participants who work in appetite or feeding related areas&#xD;
&#xD;
          -  Participants not able to comply with the study protocol&#xD;
&#xD;
          -  Post-menopausal&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Graham Finlayson, Ass Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Liverpool</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Nutrition Exercise and Sports</name>
      <address>
        <city>Copenhagen</city>
        <zip>1958</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>October 13, 2014</study_first_submitted>
  <study_first_submitted_qc>October 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2014</study_first_posted>
  <last_update_submitted>March 16, 2015</last_update_submitted>
  <last_update_submitted_qc>March 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>Anders Mikael Sjödin, MD, PHD ass professor</investigator_full_name>
    <investigator_title>Associated Professor</investigator_title>
  </responsible_party>
  <keyword>Ad libitum energy intake</keyword>
  <keyword>Appetite sensation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

